Trial Holdings Inc carries a market capitalization of 385.10B, placing it among publicly traded companies globally. Its enterprise value stands at 654.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 385.10B |
| Enterprise Value | 654.49B |
Trial Holdings Inc currently has 122.39M shares outstanding.
| Shares Outstanding | 122.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Trial Holdings Inc trades at a trailing price-to-earnings ratio of 68.39.
| PE Ratio | 68.39 |
| PS Ratio | N/A |
| PB Ratio | 3.65 |
| P/TBV Ratio | -2.12 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Trial Holdings Inc maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.39 |
| Quick Ratio | 0.18 |
| Debt / Equity | 295.31 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Trial Holdings Inc's stock has gained approximately 25.29928% over the past 52 weeks. The 50-day moving average sits at 3,201.74, while the 200-day moving average is 3,157.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.29928% |
| 50-Day Moving Average | 3,201.74 |
| 200-Day Moving Average | 3,157.80 |
| Average Volume (20 Days) | N/A |
Trial Holdings Inc holds 116.40B in cash and equivalents against 388.98B in total debt, resulting in a net debt position of 272.58B. Total book value stands at 103.87B, with working capital of -398.24B providing operational flexibility.
| Cash & Cash Equivalents | 116.40B |
| Total Debt | 388.98B |
| Net Debt | 272.58B |
| Equity (Book Value) | 103.87B |
| Book Value Per Share | 850.18 |
| Working Capital | -398.24B |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Profit Margin | N/A |
| EBITDA Margin | 2.08 |
Trial Holdings Inc posts an Altman Z-Score of -0.35, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.35 |